1. Home
  2. RDHL vs IMTE Comparison

RDHL vs IMTE Comparison

Compare RDHL & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • IMTE
  • Stock Information
  • Founded
  • RDHL 2009
  • IMTE 2008
  • Country
  • RDHL Israel
  • IMTE Malaysia
  • Employees
  • RDHL N/A
  • IMTE N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • IMTE Consumer Electronics/Appliances
  • Sector
  • RDHL Health Care
  • IMTE Consumer Staples
  • Exchange
  • RDHL Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • RDHL 3.8M
  • IMTE 4.1M
  • IPO Year
  • RDHL N/A
  • IMTE N/A
  • Fundamental
  • Price
  • RDHL $1.85
  • IMTE $0.99
  • Analyst Decision
  • RDHL
  • IMTE
  • Analyst Count
  • RDHL 0
  • IMTE 0
  • Target Price
  • RDHL N/A
  • IMTE N/A
  • AVG Volume (30 Days)
  • RDHL 18.5K
  • IMTE 10.6K
  • Earning Date
  • RDHL 04-10-2025
  • IMTE 07-07-2025
  • Dividend Yield
  • RDHL N/A
  • IMTE N/A
  • EPS Growth
  • RDHL N/A
  • IMTE N/A
  • EPS
  • RDHL N/A
  • IMTE N/A
  • Revenue
  • RDHL $8,042,999.00
  • IMTE $123,337.00
  • Revenue This Year
  • RDHL $381.91
  • IMTE N/A
  • Revenue Next Year
  • RDHL N/A
  • IMTE N/A
  • P/E Ratio
  • RDHL N/A
  • IMTE N/A
  • Revenue Growth
  • RDHL 23.17
  • IMTE 4.75
  • 52 Week Low
  • RDHL $1.71
  • IMTE $0.51
  • 52 Week High
  • RDHL $20.28
  • IMTE $3.17
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 43.03
  • IMTE 34.23
  • Support Level
  • RDHL $1.72
  • IMTE $0.87
  • Resistance Level
  • RDHL $2.08
  • IMTE $1.02
  • Average True Range (ATR)
  • RDHL 0.09
  • IMTE 0.05
  • MACD
  • RDHL 0.01
  • IMTE -0.01
  • Stochastic Oscillator
  • RDHL 27.78
  • IMTE 41.93

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: